Isotopia Molecular Imaging LTD
Isotopia aspired to be the world leader and innovative company in nuclear medicine by providing meaningful medical care for patients globally.
Isotopia is a Radio Pharmaceutical Company established in 2006.
Isotopia was founded by a highly trained group of senior professionals, experienced in all aspects of radio-pharmaceutical operations, in collaboration with a group of Canadian investors.
Isotopia’s experienced and highly skilled team, together with its Radio-Pharmaceutical Company and cyclotron facility, provide a sound platform for successful commercial activities, research and development initiatives.
Isotopia operates a PETtrace Cyclotron (GE Healthcare), supplying both PET and SPECT tracers, 18F-labeled products, 177-Lu treatments for prostate cancer and neuroendocrine tumors, cold kit for 68-Ga-PSMA-11 synthesis, manufactured under strict Quality Control.
Brands: isoPROtrace11® - PSMA Coldkit
On June 14th, 2020 at 16:30 in Isotopia booth (163#) we are launching Isotopia new product: Lu-177 n.c.a.